Bedside Chat: Women in Business
Date & Time
What does business look like when women leaders are elevated?
Out of the Fortune 500 companies, only 32 have female CEOs. Only 20% of all business investment goes into women-led businesses — and it’s worse for businesses owned by trans women and women of color. The list of inequalities continues.
These are issues that B Corp certification addresses to steward business to a more equal and inclusive future. Join us to hear from women leaders of B Corps about how to build better businesses and the unique potential of women-led businesses.
The Bedside Chats are ongoing monthly series with Leesa, B Lab, and Be Social Change, bringing together innovative B Corps and businesses.
What You’ll Learn
Insights on why women-led businesses are an important metric for social change Career journeys from women who lead some of the most innovative and advanced organizations What effective governance looks like when women hold leadership roles Trends, challenges, and opportunities in women’s leadership The role male allies need to play in the workforce Strategies to promote inclusion and diversity in the workplace Everyday practices to support socially conscious companies Career opportunities at innovative businesses that excel in promoting equality in the workplace About Be Social Change Events
In addition to gaining a deeper understanding of how you can make an impact through your career, you’ll also have an opportunity to build your network by connecting with like-minded people from the Be Social Change, Leesa and B Lab communities.
Healthy + Sustainable Snacks Provided – Gluten-Free and Vegan Options Available. We strive to produce as minimal waste as possible during Be Social Change events – help us by bringing a reusable water bottle to the event
SCHEDULE 6:30 – 7:00 pm – Networking 7:00 – 8:00 pm – Panel Discussion 8:00 – 8:30 pm – Networking
FEATURED PANELISTS Brita Turner, Chief Marketing Officer, Leesa Kristy Wallace, CEO, Ellevate Network Camilia Aberra, Sr. Manager, Communications and Public Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson